Stanford School of Medicine /Division of Neuromuscular Medicine — Palo Alto, California

Stanford School of Medicine /Division of Neuromuscular Medicine is a clinical research site located in Palo Alto, California, United States 94304.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Stanford School of Medicine /Division of Neuromuscular Medicine has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Duchenne Muscular Dystrophy.

Sponsors: REGENXBIO Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Palo Alto

Browse all research sites in California · View every site in Palo Alto

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford School of Medicine /Division of Neuromuscular Medicine?

Stanford School of Medicine /Division of Neuromuscular Medicine has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford School of Medicine /Division of Neuromuscular Medicine conducted?

Stanford School of Medicine /Division of Neuromuscular Medicine has 2 clinical trials on record, with 2 currently active. Their work covers Duchenne Muscular Dystrophy.

Is Stanford School of Medicine /Division of Neuromuscular Medicine accredited by Crixeo Clinical Trials?

Stanford School of Medicine /Division of Neuromuscular Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford School of Medicine /Division of Neuromuscular Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.